Chemed (CHE) Common Equity (2009 - 2026)

Chemed (CHE) has reported Common Equity for 18 consecutive years, with $848.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Common Equity fell 28.24% year-over-year to $848.0 million; the TTM figure through Mar 2026 stood at $848.0 million (down 28.24% YoY), while the FY2025 annual figure was $979.4 million, down 12.47% from the prior year.
• Common Equity came in at $848.0 million for Q1 2026 at Chemed, down from $979.4 million in the prior quarter.
• The five-year high for Common Equity was $1.2 billion in Q3 2024, with the low at $666.7 million in Q1 2022.
• Average Common Equity over 5 years is $991.8 million, with a median of $1.0 billion recorded in 2023.
• Across the five-year window, Common Equity surged 41.28% in 2023 and decreased 28.24% in 2026, its largest moves.
• Year by year, Common Equity stood at $798.7 million in 2022, then jumped by 38.71% to $1.1 billion in 2023, then grew by 1.0% to $1.1 billion in 2024, then decreased by 12.47% to $979.4 million in 2025, then slipped by 13.42% to $848.0 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $848.0 million, $979.4 million, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.